Uric acid and incident kidney disease in the community.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2007101075PMID 18337481PMCID PMC2396939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115: 2526-2532, 2007.

  2008cited by this paper
• Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome

  2007cited by this paper
• Plasma uric acid level and risk for incident hypertension among men.

  2007cited by this paper
• Cardiovascular disease and subsequent kidney disease.

  2007cited by this paper
• Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents

  2007cited by this paper
• Prevalence of the metabolic syndrome in individuals with hyperuricemia.

  2007cited by this paper
• Relationship of uric acid with progression of kidney disease.

  2007cited by this paper
• Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.

  2006cited by this paper
• Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.

  2006cited by this paper
• Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.

  2006cited by this paper
• Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

  2006cited by this paper
• Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study.

  2006cited by this paper
• Uric acid, the metabolic syndrome, and renal disease.

  2006cited by this paper
• Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.

  2005cited by this paper
• Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study.

  2005cited by this paper
• Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study.

  2005cited by this paper
• Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

  2005cited by this paper
• Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.

  2004cited by this paper
• Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation

  2003cited by this paper
• Mild hyperuricemia induces glomerular hypertension in normal rats.

  2002cited by this paper
• A role for uric acid in the progression of renal disease.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects.

  2001cited by this paper
• Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism

  2001cited by this paper
• A simplified equation to predict glomerular filtration rate from serum creatinine

  2000cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

  1989cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper

• Explainable machine learning integrating biochemical and metabolomic biomarkers with conventional clinical factors improves chronic kidney disease prediction and risk stratification

  2026cites this paper
• Multivariate phenotyping of chronic kidney disease: a discriminant analysis study

  2026influential citation
• Serum Uric Acid Levels and Renal Function in Untreated Hypertensive Patients

  2026cites this paper
• Comparative analysis of hyperuricemia induction methods and probiotic interventions in mice

  2025cites this paper
• Assessment of Serum Uric Acid Levels in Chronic Kidney Disease Patients: A Cross-Sectional Study in A Tertiary Care Hospital

  2025cites this paper
• Hyperuricemia in patients with chronic kidney disease: When and what to treat?

  2025cites this paper
• Effects of Stevia on Inflammatory Markers, Renal and Hematological Parameters in Patients With Stage I-III Chronic Kidney Disease: A Randomized, Placebo-Controlled Clinical Trial in Bangladesh

  2025cites this paper
• Crystal clear - part I: The role of uric acid in cardiorenal disease.

  2025cites this paper
• Uric Acid Trajectories and CKD Progression in the African American Study of Kidney Disease and Hypertension

  2025cites this paper
• Innovative modeling: a diet-induced quail model for progressive pathological changes in uric acid metabolism disorders

  2025cites this paper
• Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study

  2025cites this paper
• Gut microbiota-derived SCFAs and MetS-related nephropathy

  2025cites this paper
• Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

  2025cites this paper
• Unraveling the effects of uric acid on endothelial cells: A global proteomic study

  2025cites this paper
• Dietary index for gut microbiota and its protective role against kidney stones: evidence of diabetes as a mediator from NHANES cross-sectional data

  2025cites this paper
• The role of hyperuricemia in the progression of end‐stage kidney disease and its molecular prospective in inflammation and cardiovascular diseases: A general review

  2025cites this paper
• Cardiovascular and Metabolic Effects of Febuxostat in Patients with Stage 3–4 Chronic Kidney Disease and Asymptomatic Hyperuricemia: A Prospective Observational Study

  2025cites this paper
• Association of serum uric acid with all-cause and cardiovascular mortality in chronic kidney disease stages 3-5.

  2024cites this paper
• Long-term ambient air pollution exposure and renal function and biomarkers of renal disease

  2024cites this paper
• Preventive effect of Lactobacillus johnsonii YH1136 against uric acid accumulation and renal damages

  2024cites this paper
• Analysis of risk factors for abnormal renal function in patients with gout in Southwest China: a cross-sectional study

  2024cites this paper
• Association of serum uric acid to serum creatinine ratio with 1‐year stroke outcomes in patients with acute ischemic stroke: A multicenter observational cohort study

  2024cites this paper
• Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease

  2024cites this paper
• The association between the presence of kidney stones and the risk of developing osteoporosis: a NHANES-based cross-sectional study and Mendelian randomization analysis

  2024cites this paper
• Generalized Propensity Score Methods to Assess CKD-Associated Physiologic Factors and Risk of Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study.

  2024cites this paper
• Impaired kidney function among young healthcare workers with long working hours and night work

  2024cites this paper
• Biomedical Evaluation of Early Chronic Kidney Disease in the Air Force: Building a Predictive Model from the Taiwan Military Health Service

  2024cites this paper
• Evaluating the causal relationships between urate, blood pressure, and kidney function in the general population: a two-sample Mendelian Randomization study

  2024cites this paper
• Association of Smoking with Chronic Kidney Disease Stages 3 to 5: A Mendelian Randomization Study

  2024cites this paper
• Association between serum uric acid and kidney disease with pediatric focus

  2024cites this paper
• Biomarkers of Kidney Disease Progression in ADPKD

  2024cites this paper
• Comparative Levels of Urinary Biomarkers of Renal Injury and Inflammation Among Patients With Diabetic Nephropathy With or Without Hyperuricemia

  2024cites this paper
• Hyperuricemia: An Intriguing Connection to Metabolic Syndrome, Diabetes, Kidney Disease, and Hypertension

  2024cites this paper
• Association of serum uric acid with all-cause and cardiovascular mortality in cardiovascular disease patients

  2024cites this paper
• Association of Metabolic Syndrome and Other Factors with the Presence of Diabetic Nephropathy in Type 2 Diabetic Patients

  2023cites this paper
• Identification of end‐stage renal disease metabolic signatures from human perspiration

  2023influential citation
• Synergetic Association between Anemia and Hyperuricemia on New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study

  2023cites this paper
• The Impact of Serum Parameters Associated with Kidney Function on the Short-Term Outcomes and Prognosis of Colorectal Cancer Patients Undergoing Radical Surgery

  2023cites this paper
• Exposure to ambient air pollutants is associated with an increased incidence of hyperuricemia: A longitudinal cohort study among Chinese government employees.

  2023cites this paper
• Association between serum albumin and new-onset hyperuricemia among participants with hypertension

  2023cites this paper
• Association of blood pressure and hyperuricemia with proteinuria and reduced renal function in the general population

  2023cites this paper
• Eurycoma longifolia alkaloid components ameliorate hyperuricemic nephropathy via regulating serum uric acid level and relieving inflammatory reaction

  2023influential citation
• Serum Urate Monitoring Among Older Adults With Gout: Initiating Urate‐Lowering Therapy in Ontario, Canada

  2023cites this paper
• Plasma Metabolomics of Dietary Intake of Protein-Rich Foods and Kidney Disease Progression in Children.

  2023cites this paper
• Allopurinol and renal impairment; as review on current findings

  2023cites this paper
• Serum uric acid levels in kidney transplant recipients: A cause for concern? A review of recent literature.

  2023cites this paper
• Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure

  2023cites this paper
• Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease

  2023cites this paper
• Concentration of serum uric acid in patients with Renal Artery Stenosis and Hypertension prEdict Future nephropathy and death: C‐RASHEF study

  2023cites this paper
• Lipidomics analysis facilitate insight into the molecular mechanisms of urate nephropathy in a gout model induced by combination of MSU crystals injection and high-fat diet feeding

  2023cites this paper
• The regulatory role of miRNA towards expressed genes in the pathogenesis of gout: A review

  2023cites this paper
• A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease

  2022cites this paper
• Uric Acid and Impairment of Renal Function in Non-diabetic Hypertensive Patients

  2022influential citation
• Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease

  2022cites this paper
• Prevalence of Chronic Kidney Disease After Heart Transplant: A Single Center Experience

  2022cites this paper
• Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD

  2022cites this paper
• Lifestyle-Related Risk Factors for the Incidence and Progression of Chronic Kidney Disease in the Healthy Young and Middle-Aged Population

  2022cites this paper
• Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population

  2022cites this paper
• Evaluation of the Effect of Topiroxostat on Renal Function in Patients with Hyperuricemia: STOP-C Study, a Retrospective Observational Cohort Study

  2022cites this paper
• Sex Difference in the Associations among Hyperuricemia with New-Onset Chronic Kidney Disease in a Large Taiwanese Population Follow-Up Study

  2022cites this paper
• POSSIBILITIES OF RENOPROTECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERURICEMIA.

  2022cites this paper
• The effect of trajectory of serum uric acid on survival and renal outcomes in patients with stage 3 chronic kidney disease

  2022cites this paper
• Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease

  2022cites this paper
• Is Renoprotection Real for Patients with Hyperuricemia?

  2022cites this paper
• Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis

  2022cites this paper
• Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non‐Asian participants

  2022cites this paper
• Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging

  2022cites this paper
• Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease

  2022cites this paper
• PREDICTIVE MARKERS IN CHRONIC KIDNEY DISEASE.

  2022cites this paper
• Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease

  2022cites this paper
• Genetic risk score for plasma uric acid levels is associated with early rapid kidney function decline in type 2 diabetes.

  2022cites this paper
• Effect Modification of Hyperuricemia, Cardiovascular Risk, and Age on Chronic Kidney Disease in China: A Cross-Sectional Study Based on the China Health and Nutrition Survey Cohort

  2022cites this paper
• The Negative Association Between NAFLD Severity and CKD in a Non-diabetic Gouty Population.

  2022cites this paper
• Colchicine use and the risk of CKD progression: A multicenter nested case-control study.

  2022cites this paper
• A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease

  2022cites this paper
• Development of chronic kidney disease influenced by serum urate and body mass index based on young-to-middle-aged Japanese men: a propensity score-matched cohort study

  2022cites this paper
• Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression

  2022cites this paper
• Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?

  2022cites this paper
• Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease

  2021cites this paper
• Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria

  2021cites this paper
• The role of uric acid in renal damage - A history of inflammatory pathways and vascular remodeling

  2021cites this paper
• Alcohol consumption and serum uric acid are synergistically associated with renal dysfunction among community‐dwelling persons

  2021cites this paper
• Medications for gout and its comorbidities: mutual benefits?

  2021cites this paper
• Serum Uric Acid Levels and Risk of Eight Site-Specific Cancers: A Mendelian Randomization Study

  2021cites this paper
• Hyperuricemia and chronic kidney disease: to treat or not to treat

  2021cites this paper
• Identification of Abnormal Proteins in Plasma from Gout Patients by LC-MS/MS

  2021cites this paper
• Association between urbanisation and the risk of hyperuricaemia among Chinese adults: a cross-sectional study from the China Health and Nutrition Survey (CHNS)

  2021cites this paper
• Methyl Gallate Improves Hyperuricemia Nephropathy Mice Through Inhibiting NLRP3 Pathway

  2021cites this paper
• Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China

  2021cites this paper
• Calcitriol Treatment Attenuates Uric Acid-Induced Kidney Injury via Super Oxide Dismutase-1 (SOD-1) Upregulation and Fibrosis Reduction.

  2021cites this paper
• The Role of Hyperuricemia in the Pathogenesis and Progressivity of Chronic Kidney Disease

  2021cites this paper
• Serum uric acid and risk of incident chronic kidney disease: a national cohort study and updated meta-analysis

  2021cites this paper
• Factors Influencing the Serum Uric Acid in Gout with Cerebral Infarction

  2021cites this paper
• Can uric acid blood levels in renal transplant recipients predict allograft outcome?

  2021cites this paper
• The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems.

  2021cites this paper
• Identification of Abnormal Proteins in Plasma from Gout Patients by LC-MS/MS

  2021cites this paper
• A case-control study

  2021cites this paper
• Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients

  2021cites this paper
• A REVIEW AND CASE STUDY TO DESIGN A PROGNOSTIC MODEL FOR GOUT IN PATIENTS WITH ROSACIC ACID

  2021cites this paper
• Sex-Specific Association of Uric Acid and Kidney Function Decline in Taiwan

  2021cites this paper